S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.11%) $0.928
USD/NOK
(0.28%) $10.87
USD/GBP
(-0.04%) $0.792
USD/RUB
(-0.03%) $92.55

Realtime updates for Bausch Health Companies [BHC]

Exchange: NYSE Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated28 Mar 2024 @ 16:00

1.14% $ 10.61

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology...

Stats
Today's Volume 3.59M
Average Volume 2.38M
Market Cap 3.88B
EPS $0 ( 2024-02-22 )
Next earnings date ( $0.740 ) 2024-05-02
Last Dividend $1.000 ( 2010-11-10 )
Next Dividend $0 ( N/A )
P/E -6.55
ATR14 $0.0140 (0.13%)
Insider Trading
Date Person Action Amount type
2024-02-29 Barresi John S Buy 39 126 Common Shares, No Par Value
2024-03-01 Barresi John S Sell 3 188 Common Shares, No Par Value
2024-02-29 Appio Thomas Buy 519 328 Common Shares, No Par Value
2024-03-01 Appio Thomas Sell 2 895 Common Shares, No Par Value
2024-03-01 Appio Thomas Sell 2 413 Common Shares, No Par Value
INSIDER POWER
70.59
Last 100 transactions
Buy: 2 817 374 | Sell: 351 543

Volume Correlation

Long: -0.09 (neutral)
Short: 0.45 (neutral)
Signal:(39.365) Neutral

Bausch Health Companies Correlation

10 Most Positive Correlations
YSAC0.851
PKE0.81
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bausch Health Companies Correlation - Currency/Commodity

The country flag -0.06
( neutral )
The country flag -0.29
( neutral )
The country flag 0.00
( neutral )
The country flag -0.04
( neutral )
The country flag 0.00
( neutral )
The country flag -0.31
( neutral )

Bausch Health Companies Financials

Annual 2023
Revenue: $8.76B
Gross Profit: $6.20B (70.78 %)
EPS: $-1.620
Q4 2023
Revenue: $2.41B
Gross Profit: $4.22B (175.33 %)
EPS: $1.110
Q3 2023
Revenue: $2.24B
Gross Profit: $1.62B (72.16 %)
EPS: $-1.030
Q2 2023
Revenue: $2.17B
Gross Profit: $1.52B (70.05 %)
EPS: $0.0700

Financial Reports:

No articles found.

Bausch Health Companies Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Bausch Health Companies Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 6.11 - average (70.51%) | Divividend Growth Potential Score: 2.75 - No dividend growth expected in the near future
Information
First Dividend $0.500 2005-11-28
Last Dividend $1.000 2010-11-10
Next Dividend $0 N/A
Payout Date 2010-12-22
Next Payout Date N/A
# dividends 22 --
Total Paid Out $6.43 --
Avg. Dividend % Per Year 0.00% --
Score 3.05 --
Div. Sustainability Score 6.11
Div.Growth Potential Score 2.75
Div. Directional Score 4.43 --
Next Divdend (Est)
(2024-06-07)
$0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
3.05
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2005 $0.500 3.07%
2006 $0.500 2.01%
2007 $2.00 9.47%
2008 $1.500 11.20%
2009 $0.645 6.68%
2010 $1.280 8.72%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
MTR Dividend Royal 2023-10-30 Monthly 39 10.10% 8.50
GOF Dividend Royal 2023-11-14 Monthly 18 8.03% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
KIO Dividend Royal 2023-12-14 Monthly 12 7.05% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.01901.500-0.379-0.569[0 - 0.5]
returnOnAssetsTTM-0.006071.200-0.202-0.243[0 - 0.3]
returnOnEquityTTM0.1711.5009.2110.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.3010.8008.506.80[1 - 3]
quickRatioTTM0.6850.800-0.679-0.543[0.8 - 2.5]
cashRatioTTM0.2201.5009.8910.00[0.2 - 2]
debtRatioTTM0.819-1.50010.00-10.00[0 - 0.6]
interestCoverageTTM-0.7251.000-1.380-1.380[3 - 30]
operatingCashFlowPerShareTTM3.092.008.9710.00[0 - 30]
freeCashFlowPerShareTTM2.302.008.8510.00[0 - 20]
debtEquityRatioTTM-21.91-1.500-10.0010.00[0 - 2.5]
grossProfitMarginTTM0.9951.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.1101.0009.809.80[0.1 - 0.6]
cashFlowToDebtRatioTTM0.04891.000-0.839-0.839[0.2 - 2]
assetTurnoverTTM0.3200.800-1.199-0.959[0.5 - 2]
Total Score6.11

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-22.401.000-2.360[1 - 100]
returnOnEquityTTM0.1712.509.4910.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.302.009.2310.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM3.092.008.9710.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.4561.500-6.370[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1251.0009.370[0.1 - 0.5]
Total Score2.75

Bausch Health Companies

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators